Related Experiment Videos
Vascular protection in brain ischemia
Manuel Rodríguez-Yáñez1, Mar Castellanos, Miguel Blanco
1Department of Neurology, Division of Vascular Neurology, Hospital Clínico Universitario, University of Santiago de Compostela, Spain.
Cerebrovascular Diseases (Basel, Switzerland)
|May 3, 2006
Summary
Vascular damage after stroke worsens outcomes. Targeting the chronic phase of cerebral ischemia with drugs like statins and erythropoietin offers a viable therapeutic window for vascular protection.
Area of Science:
- Neuroscience
- Cardiovascular Science
- Pharmacology
Background:
- Vascular damage post-cerebral ischemia exacerbates patient outcomes by promoting edema and hemorrhagic transformation.
- Vascular injury develops across acute, subacute, and chronic phases, each involving distinct mediators.
Purpose of the Study:
- To review therapeutic strategies for mitigating vascular injury following cerebral ischemia.
- To identify drugs offering vascular protection during the chronic phase of ischemic stroke.
Main Methods:
- Literature review of experimental and clinical studies on vascular injury in cerebral ischemia.
- Analysis of therapeutic interventions targeting different phases of vascular damage.
Main Results:
- While interventions show promise in acute and chronic phases, the chronic phase presents a wider therapeutic window for vascular protection.
- Drugs such as erythropoietin, statins, angiotensin modulators, minocycline, and thiazolidinediones demonstrate vascular protective effects in ischemic stroke patients.
Conclusions:
- Therapeutic interventions for vascular injury must address each phase of development.
- The chronic phase of cerebral ischemia is a key target for developing effective vascular protection strategies in clinical practice.